WallStreetZenWallStreetZen

NASDAQ: CLLS
Cellectis Sa Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CLLS stock forecasts and price targets.

Forecast return on equity

Is CLLS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.8%

Forecast return on assets

Is CLLS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CLLS revenue growth forecast

How is CLLS forecast to perform vs Biotechnology companies and vs the US market?
Company
115.48%
Industry
35.36%
Market
10.44%
CLLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLLS$2.82N/AN/A
CMPX$1.47$9.00+512.24%Buy
GBIO$3.07$7.50+144.30%Buy
ABOS$3.40$11.50+238.24%Strong Buy
INMB$10.11N/AN/A

Cellectis Sa Stock Forecast FAQ

What is CLLS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CLLS) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Cellectis Sa stock.

What is CLLS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CLLS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.